News

BiO€QUITY Europe on 17-19 May 2021

Date
May 17, 2021
No items found.

MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients.

To date, we have developed and validated novel biomarker signatures for PARPi and CKD4/6i.

Feel free to request meeting to learn more about MNM Diagnostics during BiO€QUITY Europe conference on 17-19 May 2021

‍

BiO€QUITY Europe on 17-19 May 2021
June 22, 2022
BiO€QUITY Europe on 17-19 May 2021
BiO€QUITY Europe on 17-19 May 2021
June 22, 2022
Europe Biobank Week 2021
Europe Biobank Week 2021
June 22, 2022
Our latest Nature Immunology article has been just released
Our latest Nature Immunology article has been just released
June 9, 2022
Publication in Molecular Diagnosis & Therapy has been just released
Publication in Molecular Diagnosis & Therapy has been just released
June 7, 2022
MNM Bioscience announced that it had filed a provisional patent application
MNM Bioscience announced that it had filed a provisional patent application
June 15, 2022
Alliance Visionary Leaders “Future of Health & Healthcare” Roundtable
Alliance Visionary Leaders “Future of Health & Healthcare” Roundtable
June 9, 2022
MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project
MNM Bioscience received $800 000 funding through Eureka Eurostars for our newest project
June 9, 2022
5th DNA Repair/Replication Structures and Cancer Conference
5th DNA Repair/Replication Structures and Cancer Conference
June 9, 2022
MNM Bioscience eyes cancer drug target discovery based on its AI algorithms
MNM Bioscience eyes cancer drug target discovery based on its AI algorithms
June 23, 2022
MNM Bioscience joins ESMO Breast Cancer 2022
MNM Bioscience joins ESMO Breast Cancer 2022
September 15, 2022
Krzysztof Bokiej is a speaker at Data Science Summit ML Edition
Krzysztof Bokiej is a speaker at Data Science Summit ML Edition
June 23, 2022
“Random similarity forests” has been accepted at ECML PKDD 2022
“Random similarity forests” has been accepted at ECML PKDD 2022
July 6, 2022
MNM's platform ARETE works!
MNM's platform ARETE works!
July 26, 2022
Distribution-based feature extraction from copy number and structural variants in whole-genome data
Distribution-based feature extraction from copy number and structural variants in whole-genome data
August 9, 2022
MNM at the ESMO 2022 Congress
MNM at the ESMO 2022 Congress
September 22, 2022
Greetings from ECML PKDD 2022!
Greetings from ECML PKDD 2022!
September 23, 2022
Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board
Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board
January 12, 2023

You may also like

Publication in Molecular Diagnosis & Therapy has been just released

MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics.

BiO€QUITY Europe on 17-19 May 2021

MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients.

Our latest Nature Immunology article has been just released

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.